{
    "data": [
        {
            "id": "4511956",
            "title": "Intensity Therapeutics surges 395% on phase 1/2 data for solid tumors asset",
            "description": "<html><body><p>Intensity Therapeutics (<span class=\"ticker-hover-wrapper\"><span class=\"ticker-hover-wrapper\"><span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/INTS\" title=\"Intensity Therapeutics, Inc.\">INTS</a></span></span></span>), with a ~$13M market cap, closed <span style=\"color: #008000;\">up nearly 395%</span> Thursday after publishing phase 1/2 results on its candidate for metastatic or refractory cancers, INT230-6.</p>\n<p>The asset works by diffusion of cytotoxic agents, cisplatin and vinblastine sulfate, using direct injection into a tumor. The treatment also utilizes a cell penetration enhancer molecule (\"SHAO\") that conjugates to the two drugs. Results indicated an increase in activated CD4+ and CD8+ T cells in the tumor microenvironment, the company said.</p>\n<p>The 64 patients enrolled in the study had over 20 different types of cancer and were heavily pretreated.</p>\n<p>Data <a href=\"https://seekingalpha.com/pr/20286074-intensity-therapeutics-inc-announces-publication-of-clinical-results-of-int230minus-6-for-the\" target=\"_self\" title=\"showed\">showed</a> a disease control rate of 75% and median overall survival of 11.9 months. In a metastatic sarcoma patient subset, mOS was 21.3 months.</p>\n<p>No grade 4 or 5 treatment-related adverse events were reported, though seven participants reported a grade 3. Also, there were no dose-limiting toxicities.</p>\n<p>CEO and Founder Lewis Bender told Seeking Alpha, \"Evidently, the market reacted positively to the data and the results...which indicates to us that this topic, and hopefully our research, resonates with many people. This early data is demonstrating the potential of a new way to treat cancer that we hope could benefit many patients.\"</p>\n<p>Intensity has collaborations with Merck (<a href=\"https://seekingalpha.com/symbol/MRK\" title=\"Merck &amp; Co., Inc.\">MRK</a>) and Bristol Myers Squibb (<a href=\"https://seekingalpha.com/symbol/BMY\" title=\"Bristol-Myers Squibb Company\">BMY</a>) that are examining INT230-6 in combination with, respectively, Keytruda (pembrolizumab) and Yervoy (ipilimumab).Â </p>\n<p>The company will <a href=\"https://event.choruscall.com/mediaframe/webcast.html?webcastid=6uG6ARFf\" rel=\"nofollow\" target=\"_blank\" title=\"hold\">hold</a> a conference call on Oct. 31 at 9a ET to discuss the results, which were published in the journal <em><a href=\"https://www.sciencedirect.com/science/article/pii/S2352396425004244\" rel=\"nofollow\" target=\"_blank\" title=\"eBioMedicine\">eBioMedicine</a></em>.</p>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511956-intensity-therapeutics-surges-395-percent-phase-1-2-data-solid-tumors-asset",
            "pub_date": "2025-10-31 06:05:57",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511970",
            "title": "XPO signals continued margin expansion into 2026 as AI and premium services drive pricing and productivity gains",
            "description": "<html><body><p>Earnings Call Insights: XPO, Inc. (XPO) Q3 2025</p>\n<h3>Management View</h3>\n<ul>\n<li>CEO Mario Harik reported that \"we generated adjusted EBITDA of $342 million and adjusted diluted EPS of $1.07, both exceeding expectations.\" Harik highlighted that North American LTL adjusted operating income grew by 10% year-over-year to $217 million with a 150 basis point improvement in adjusted operating ratio to 82.7%. He stated, \"We grew LTL adjusted EBITDA to the highest level of any quarter in our history at $308 million.\"</li>\n<li>Harik emphasized the company's ability to \"drive above-market yield growth\" and optimize the network with proprietary AI and technology. He noted, \"We reduced damage frequency to the best level in our history, and we improved on-time performance year-over-year for the 14th consecutive quarter.\"</li>\n<li>Investments in fleet have lowered the average age of tractors to 3.6 years, with a \"10% reduction in our maintenance cost per mile,\" according to Harik.</li>\n<li>The CEO detailed, \"We improved outsourced miles to 5.9% of total miles, the lowest level in company history and down from 25% a few years ago.\"</li>\n<li>CFO Kyle Wismans stated, \"For the third quarter, total company revenue was up 3% year-over-year to $2.1 billion. In our LTL segment, revenue was also up to $1.3 billion.\" Wismans added, \"Our AI-driven tools helped to offset the impact of inflation and the added labor cost from our in-sourcing initiative.\"</li>\n<li>Wismans reported, \"Operating income was $164 million and net income was $82 million. Diluted earnings per share decreased to $0.68, reflecting a $35 million charge related to a legal matter dating back to Con-way in the 1980s before we acquired the company.\" On an adjusted basis, diluted EPS was $1.07, up 5% year-over-year.</li>\n<li>Chief Strategy Officer Ali-Ahmad Faghri noted, \"Shipments per day were down 3.5% year-over-year and weight per shipment declined 2.7%, resulting in a 6.1% decrease in tonnage per day.\" He highlighted, \"High-margin local shipments now represent 25% of our total, up from 20% just a few years ago.\"</li>\n</ul>\n<h3>Outlook</h3>\n<ul>\n<li>Harik indicated, \"We do expect to continue to materially outperform that seasonality here in the fourth quarter, and this implies that OR will also improve meaningfully on a year-on-year basis and accelerate versus where we were in the third quarter on a year-on-year basis is our current expectation.\"</li>\n<li>He added, \"We do expect a strong year of both OR improvement and earnings growth in 2026.\"</li>\n<li>Faghri explained, \"If you just take the 100 basis points of OR improvement, we expect for the full year that would imply a modest sequential increase in our OR as we go from Q3 to Q4, but obviously, much better than the typical 250 basis points of seasonal increase.\"</li>\n</ul>\n<h3>Financial Results</h3>\n<ul>\n<li>Total company revenue was $2.1 billion as reported by Wismans, with LTL revenue at $1.3 billion.</li>\n<li>Adjusted EBITDA was $342 million, and adjusted operating income reached $217 million in LTL, both noted as company records.</li>\n<li>LTL adjusted EBITDA margin expanded by 180 basis points to 24.5%.</li>\n<li>Cash flow from operating activities was $371 million, with $150 million deployed in net CapEx. The quarter ended with $335 million of cash and $935 million in total liquidity.</li>\n<li>The net leverage ratio was 2.4x trailing 12 months adjusted EBITDA.</li>\n</ul>\n<h3>Q&amp;A</h3>\n<ul>\n<li>Ken Hoexter, BofA Securities: Asked about October tonnage and margin expectations for Q4. Harik responded that October tonnage is \"down in the 3% range\" and reiterated expectations to \"materially outperform that seasonality here in the fourth quarter,\" with margin acceleration.</li>\n<li>Scott Group, Wolfe Research: Sought color on magnitude of margin improvement into next year. Harik replied, \"We do expect a strong year of both OR improvement and earnings growth in 2026,\" and detailed ongoing initiatives in yield and AI productivity.</li>\n<li>Jonathan Chappell, Evercore ISI: Inquired about cost line items and AI contributions. Harik explained that productivity, not just in-sourcing, was the major driver, with 2.5 points improvement in labor hours per shipment.</li>\n<li>Jordan Alliger, Goldman Sachs: Asked about incremental margins with future volume growth. CFO Wismans said, \"We'd expect those to be comfortably above 40%.\"</li>\n<li>Stephanie Moore, Jefferies: Questioned confidence in sustaining pricing strength. Harik outlined a \"run rate on a lot of these initiatives\" and a multi-year opportunity to bridge the price gap with best-in-class peers, aiming for accessorial revenue to rise from 12% to 15% over the next three years.</li>\n<li>Fadi Chamoun, BMO Capital Markets: Asked about Q4 pricing outlook. Wismans stated, \"We'd expect yield ex fuel to be in a similar growth range on a year-over-year basis what we saw in the third quarter.\"</li>\n<li>Multiple analysts probed on macro trends, volume inflection, and AI adoption, with management consistently emphasizing ongoing productivity and pricing levers and expressing optimism for 2026.</li>\n</ul>\n<h3>Sentiment Analysis</h3>\n<ul>\n<li>Analyst tone was positive but probing, focusing on sustainability of margin and pricing gains, the impact of AI, and future cash flow. There was interest in the durability of productivity improvements and pricing discipline amid a soft macro environment.</li>\n<li>Management maintained a confident and assertive tone throughout, especially regarding margin improvement and the impact of AI. Harik used language such as, \"We do expect a strong year...\" and \"we're just beginning to unlock its potential.\"</li>\n<li>Compared to the previous quarter, management continued to express strong confidence, with a slight increase in specificity around AI and premium service contributions. Analysts remained constructive but sought more detail on forward levers and macro sensitivity.</li>\n</ul>\n<h3>Quarter-over-Quarter Comparison</h3>\n<ul>\n<li>Management reiterated and expanded guidance for margin improvement, now emphasizing acceleration into 2026 and a more detailed roadmap for premium services and AI.</li>\n<li>Strategic focus shifted further toward technology-driven productivity and mix enhancement, with continued commentary on local channel growth and premium pricing.</li>\n<li>Key metrics such as revenue, adjusted EBITDA, and margin showed sequential and year-over-year improvement, with a noted record in LTL adjusted EBITDA.</li>\n<li>Analyst questions in both quarters centered on sustainability of yield and margin, but Q3 saw increased focus on the role of AI and the scale of cash flow and CapEx moderation.</li>\n<li>Sentiment remained confident from management, with analysts similarly positive but more focused on long-term levers and macro risks.</li>\n</ul>\n<h3>Risks and Concerns</h3>\n<ul>\n<li>Management acknowledged persistent softness in freight demand and a \"fairly neutral\" outlook from customers for Q4, while noting \"more optimism in terms of the overall demand outlook\" for 2026.</li>\n<li>Legal expenses impacted GAAP EPS due to a $35 million charge.</li>\n<li>Analysts raised concerns about competitive pricing, macro uncertainty, and the timing of market recovery, but management cited structural advantages in network, technology, and customer mix.</li>\n</ul>\n<h3>Final Takeaway</h3>\n<p>Management stressed that XPO's strategy of integrating advanced technology with a high-performing network continues to deliver record results and margin expansion, even in a soft macro environment. The company is positioned to accelerate earnings and margin gains as the cycle turns, with AI and premium service offerings expected to drive further improvements in productivity, pricing, and long-term shareholder value.</p>\n<p><a href=\"https://seekingalpha.com/symbol/xpo/earnings/transcripts\">Read the full Earnings Call Transcript</a></p>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511970-xpo-signals-continued-margin-expansion-into-2026-as-ai-and-premium-services-drive-pricing-and",
            "pub_date": "2025-10-31 06:00:49",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511465",
            "title": "Here are the major earnings before the open Friday",
            "description": "<html><body><p>Major earnings expected before the bell on Friday include:</p>\n<ul>\n<li>Exxon Mobil Corporation  (XOM)</li>\n<li>AbbVie (ABBV)</li>\n<li>Chevron Corporation  (CVX)</li>\n<li>Dominion Energy  (D)</li>\n<li>T. Rowe Price Group  (TROW)</li>\n</ul>\n<p>Other earnings slated for release before Friday's open include:</p>\n<ul>\n<li>[[ABR]],   [[AGCO]],   [[ALE]],   [[AON]],   [[ATR]],   [[BFLY]],   [[CBOE]],   [[CG]],   [[CHD]],   [[CHTR]],   [[CL]],   [[CNI]],   [[CVE]],   [[CVEO]],   [[FRT]],   [[GWW]],   [[IMO]],   [[ISNPY]],   [[LEA]],   [[LIN]],   [[LYB]],   [[MGA]],   [[MSGS]],   [[NINE]],   [[NVT]],   [[NWL]],   [[OIS]],   [[OMF]],   [[POR]],   [[PRLB]],   [[WT]]</li>\n<li>For Seeking Alpha's full earnings season calendar, <a href=\"https://seekingalpha.com/earnings/earnings-calendar\">click here</a>.</li>\n</ul></body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511465-here-are-the-major-earnings-before-the-open-friday",
            "pub_date": "2025-10-31 06:00:49",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511942",
            "title": "Enact Mortgage Insurance enters new credit risk transfer pact",
            "description": "<html><body><p>Enact Holdings (<span class=\"ticker-hover-wrapper\"><span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/ACT\" title=\"Enact Holdings, Inc.\">ACT</a></span></span>) said its mortgage insurance unit secured <a href=\"https://seekingalpha.com/pr/20287487-enact-mortgage-insurance-enters-into-a-forward-xol-reinsurance-transaction-as-part-of-its\" target=\"_blank\" title=\"~$170M of additional excess of loss\">~$170M of additional excess of loss</a> (\"XOL\") reinsurance coverage in a transaction that's part of its diversified credit risk transfer program.</p>\n<p>The credit risk transfer transaction covers a portion of expected new insurance written for the 2027 book year and is effective Jan. 1, 2027.Â </p>\n<p>âTodayâs transaction reflects the continued successful execution of our CRT strategy,â said Rohit Gupta, president and CEO of Enact.</p>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511942-enact-mortgage-insurance-enters-new-credit-risk-transfer-pact",
            "pub_date": "2025-10-31 05:55:44",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511965",
            "title": "Crocs outlines $100M cost savings initiative and forecasts Q4 revenues down 8% amid tariff pressures",
            "description": "<html><body><p>Earnings Call Insights: Crocs, Inc. (CROX) Q3 2025  </p>\n<h3>Management View</h3>\n<ul>\n<li>CEO Andrew Rees highlighted disciplined management of both the Crocs and HEYDUDE brands, with actions to streamline cost structure and inventory. He stated, \"We delivered very strong profitability and cash flow, which enabled us to repurchase 2.4 million of our outstanding shares and pay down $63 million of debt. These are fundamental levers of our value creation model.\" Rees acknowledged performance was ahead of expectations but not at the company's standards, emphasizing efforts to regain marketplace momentum through cost reductions and strategic brand actions.</li>\n<li>For the Crocs brand, Rees described two strategic moves: scaling back promotional activity in North American digital channels and reducing wholesale receipts to align supply with demand. He noted, \"While these actions are impacting near-term sales, we expect them to enable a foundation for future growth.\"</li>\n<li>Rees detailed ongoing product innovation, including the introduction of the crafted clog at $60 and successful launches such as the Echo RO. He pointed to international expansion, stating, \"China delivered revenue growth across all channels and was up mid-20% to prior year.\"</li>\n<li>For HEYDUDE, Rees said the brand is stabilizing in North America, with campaigns like HEYDUDE Country and new product launches. He explained, \"We are encouraged to see the brands return to the top 10 preferred footwear brands among males in the Piper Sandler Taking Stock With Teens survey this fall.\"</li>\n<li>Rees announced an additional $100 million in identified gross cost savings for the business, to follow $50 million previously actioned in 2025.</li>\n<li>CFO Patraic Reagan stated, \"Our third quarter revenue of approximately $1 billion were down 7% to prior year. Crocs Brand revenue of $836 million was down 3% to prior year, with wholesale down 8% and DTC up 1%.\" Reagan added, \"Adjusted diluted earnings per share of $2.92 was down 19% to last year, and our non-GAAP effective tax rate was 16.9%.\"</li>\n</ul>\n<h3>Outlook</h3>\n<ul>\n<li>Crocs expects Q4 revenues to be down approximately 8% at October 27 currency rates. Reagan indicated, \"We expect the Crocs brand to be down approximately 3% with acceleration in our international business from a mid-single digit in Q3 to a low double-digit rate in Q4. North America revenue is expected to be down low double digits to prior year. For HEYDUDE, we expect revenue to be down in the mid-20s range.\"</li>\n<li>Adjusted operating margin is projected at approximately 15.5% for Q4, excluding about $10 million related to cost reduction initiatives. Gross margins are anticipated to be down about 300 basis points due to tariff headwinds. Adjusted diluted EPS is expected in the range of $1.82 to $1.92.</li>\n<li>Reagan stated, \"We are already benefiting from the previously actioned $50 million of gross cost savings in 2025. In addition, we have identified $100 million of incremental gross cost savings that we expect to benefit 2026.\"</li>\n</ul>\n<h3>Financial Results</h3>\n<ul>\n<li>Crocs reported third quarter revenue of approximately $1 billion, a 7% decrease year-over-year. Crocs brand revenue was $836 million, down 3%, with wholesale down 8% and DTC up 1%. North America revenue declined 9%, with international revenue up 4%.</li>\n<li>HEYDUDE revenue was $160 million, down 22% year-over-year. DTC for HEYDUDE was down 1%, driven by retail store additions and TikTok Shop performance, while wholesale dropped 39% due to marketplace cleanup actions.</li>\n<li>Enterprise adjusted gross margin was 58.5%, down 110 basis points, with a 230 basis point headwind from tariffs. Adjusted operating margin was 20.8%, exceeding guidance but down 460 basis points. Adjusted EPS was $2.92, down 19%.</li>\n<li>Inventory balance stood at $397 million, up 8%, attributed to higher tariffs and product mix, while inventory units were down low single digits. Share repurchases totaled 2.4 million shares for $203 million in the quarter.</li>\n</ul>\n<h3>Q&amp;A</h3>\n<ul>\n<li>Jonathan Komp, Baird: Asked about incremental cost savings and structural changes. Andrew Rees explained efficiencies in supply chain and organizational restructuring, and said, \"We can achieve operating leverage in 2026.\"</li>\n<li>Komp followed up on portfolio management and HEYDUDE. Rees responded, \"We believe HEYDUDE is a strong brand... We're definitely focused on returning it to profitability... not contemplating any portfolio changes at this time.\"</li>\n<li>Chris Nardone, BofA: Queried actions to improve Crocs North America. Rees detailed product innovation, diversification, and digital engagement strategies.</li>\n<li>Tom Nikic, Needham: Asked about HEYDUDE marketplace cleanup. Rees said most cleanup actions will conclude in 2025 with less impact in 2026. Reagan noted, \"Sell-in and inventory levels are in much better line for HEYDUDE.\"</li>\n<li>Adrienne Yih-Tennant, Barclays: Asked about consumer behavior and inventory. Rees observed greater caution among mid- to lower-tier consumers, shopping closer to need. Reagan emphasized strong inventory management and that inventory growth was driven by tariffs.</li>\n<li>Peter McGoldrick, Stifel: Asked about market share in products under $100. Rees described both brands as \"democratic in nature\" with the majority of products under $100.</li>\n<li>Rakesh Patel, Raymond James: Inquired about wholesale order book and innovation. Rees projected continued declines in North America wholesale sell-in but highlighted upcoming product launches and sandals.</li>\n<li>Jay Sole, UBS: Asked about pullbacks on promotions and tariff impact. Rees confirmed promotional pullback spanned the entire quarter; Reagan quantified a 230 basis point tariff headwind for Q3.</li>\n<li>Brooke Roach, Goldman Sachs: Sought clarification on pricing strategy amid tariffs. Rees said, \"We don't price the cost, we price to market,\" with selective price increases planned.</li>\n<li>Aubrey Tianello, BNP Paribas: Requested update on store growth. Rees noted expansion in Europe and Asia, with strong performance from new stores.</li>\n<li>Anna Andreeva, Piper Sandler: Asked about $100 million cost savings cadence and DTC acceleration. Reagan said details on cost savings cadence will be provided in 2026, with North America DTC expected to be stronger in Q4.</li>\n</ul>\n<h3>Sentiment Analysis</h3>\n<ul>\n<li>Analysts expressed cautious and probing sentiment, focusing on cost savings, revenue trajectory, and the impact of tariffs and consumer caution. Several questions probed structural changes and the sustainability of cost reductions.</li>\n<li>Management maintained a confident and proactive tone in prepared remarks, frequently referencing cost savings, product innovation, and channel management. During Q&amp;A, management addressed challenges directly while reiterating confidence in strategic initiatives and brand health. Rees used phrases like \"we are confident\" and \"we believe\" when discussing future leverage and HEYDUDE's outlook.</li>\n<li>Compared to the previous quarter, analyst tone shifted from concern about revenue headwinds and brand health to deeper scrutiny of structural changes and long-term strategies. Management's tone remained focused on execution and flexibility, with added emphasis on cost controls and inventory discipline.</li>\n</ul>\n<h3>Quarter-over-Quarter Comparison</h3>\n<ul>\n<li>In Q2 2025, Crocs reported revenue growth and record gross profit, while Q3 saw a 7% decline in revenue year-over-year. Q2 emphasized international growth and brand diversification, while Q3 focused on cost discipline, inventory control, and managing through tariff impacts.</li>\n<li>Strategic focus shifted from growth and innovation in Q2 to executing cost reductions and stabilizing HEYDUDE in Q3.</li>\n<li>Management tone in Q3 was more cautionary regarding near-term expectations but maintained confidence in long-term brand recovery and efficiency gains. Analysts in Q3 pressed harder on structural changes, cost savings, and the path to renewed growth, reflecting heightened concern over sustained margin pressures and consumer headwinds.</li>\n</ul>\n<h3>Risks and Concerns</h3>\n<ul>\n<li>Management identified ongoing tariff headwinds as a significant risk, with a 230 basis point impact on gross margin in Q3 and an expected 300 basis point impact in Q4.</li>\n<li>The company acknowledged near-term sales pressure due to strategic pullbacks in promotions and wholesale receipts, especially in North America.</li>\n<li>Analysts raised concerns about consumer caution, particularly among lower-tier consumers, competitive pressures from athletic brands, and the ongoing impact of inventory and marketplace cleanup for HEYDUDE.</li>\n<li>Management is addressing risks through disciplined cost controls, inventory management, and strategic investments in product innovation and digital engagement.</li>\n</ul>\n<h3>Final Takeaway</h3>\n<p>Crocs management is moving decisively to reinforce profitability and lay a foundation for future growth, with $100 million in new cost savings targeted for 2026 and a continued focus on product innovation, international expansion, and digital engagement. While revenue and earnings were down in Q3 2025, proactive measures to manage inventory, reduce costs, and protect brand health are expected to support the company through near-term headwinds, particularly those related to tariffs and consumer caution. Management remains confident in the trajectory for both Crocs and HEYDUDE, emphasizing flexibility and operating leverage as key objectives for the year ahead.</p>\n<p><a href=\"https://seekingalpha.com/symbol/crox/earnings/transcripts\">Read the full Earnings Call Transcript</a></p>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511965-crocs-outlines-100m-cost-savings-initiative-and-forecasts-q4-revenues-down-8-percent-amid",
            "pub_date": "2025-10-31 05:50:42",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511966",
            "title": "Beneficient regains compliance with some of Nasdaq's listing requirements",
            "description": "<html><body><ul> <li>Beneficient (BENF) hasÂ regained compliance with some of Nasdaq's listing rules, the company said citing a letter received from Nasdaq.</li> <li>The company remains noncompliant with respect to the $1.00 per share bid price requirement and must regain compliance within the extension period granted by the Nasdaq Hearings Panel to avoid delisting.</li>\n<li>Beneficient plans to seek stockholder approval to effect a reverse stock split of its common stock, which the company anticipates will allow it to demonstrate compliance with the $1.00 bid price requirement for the requisite minimum 10-consecutive trading day period within the extension period granted by the panel.</li> <li>BENF  <font color=\"green\">+34.34%</font> after hours to  $0.7502.</li>\n<li>Source: <a href=\"https://seekingalpha.com/pr/20287637-beneficient-regains-compliance-with-nasdaq-periodic-filing-requirement-and-market-value-of\">Press Release</a>\n</li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511966-beneficient-regains-compliance-with-some-of-nasdaqs-listing-requirements",
            "pub_date": "2025-10-31 05:50:42",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511962",
            "title": "Federated Hermes declares $0.34 dividend",
            "description": "<html><body><ul>\n<li>Federated Hermes (FHI) declaredÂ <a href=\"https://seekingalpha.com/pr/20287495-federated-hermes-inc-reports-record-assets-under-management-with-third-quarter-2025-earnings\" target=\"_blank\">$0.34/share quarterly dividend</a>, in line with previous.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/FHI/dividends/yield?source=news_bullet\">Forward yield</a> 2.88%</li>\n<li>Payable Nov. 14; for shareholders of record Nov. 7; ex-div Nov. 7.</li>\n<li><a href=\"https://seekingalpha.com/symbol/FHI/dividends?source=news_bullet\">See FHI Dividend Scorecard, Yield Chart, &amp; Dividend Growth.</a></li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511962-federated-hermes-declares-0_34-dividend",
            "pub_date": "2025-10-31 05:45:56",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511963",
            "title": "Alerus Financial GAAP EPS of $0.65 beats by $0.06, revenue of $72.57M beats by $1.18M",
            "description": "<html><body><ul>\n<li>Alerus Financial <a href=\"https://seekingalpha.com/pr/20287613-alerus-financial-corporation-reports-third-quarter-2025-net-income-of-16_9-million\">press release</a>  (ALRS): Q3  GAAP EPS of $0.65 <font color=\"green\"> beats by $0.06</font>.</li>\n<li>Revenue of $72.57M (+42.6% Y/Y) <font color=\"green\"> beats by $1.18M</font>.</li>\n</ul></body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511963-alerus-financial-gaap-eps-of-0_65-beats-by-0_06-revenue-of-72_57m-beats-by-1_18m",
            "pub_date": "2025-10-31 05:45:56",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511940",
            "title": "Knight Therapeutics announces launch of JORNAY PM",
            "description": "<html><body><ul>\n<li>Knight Therapeutics (<span class=\"ticker-hover-wrapper\">GUD:CA</span>)Â <a href=\"https://seekingalpha.com/pr/20287623-knight-therapeutics-announces-launch-of-jornay-pm-in-canada\" target=\"_blank\" title=\" announced \"> announced </a>on Thursday the launch of JORNAY PM (methylphenidate HCI extended-release capsules) in Canada, a stimulant medication for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in children 6-12 years of age.</li>\n<li>The company had entered into an agreement with Ironshore Pharmaceuticals &amp; Development, a wholly owned subsidiary of Ironshore Therapeutics, for JORNAY PM, approved in November 2024 to start distribution in Canada and Latin America.Â </li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511940-knight-therapeutics-announces-launch-of-jornay-pm",
            "pub_date": "2025-10-31 05:40:44",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511955",
            "title": "Savers Value Village Non-GAAP EPS of $0.14 in-line, revenue of $426.93M in-line",
            "description": "<html><body><ul>\n<li>Savers Value Village <a href=\"https://seekingalpha.com/pr/20287336-savers-value-village-inc-reports-third-quarter-financial-results\">press release</a>  (SVV): Q3  Non-GAAP EPS of $0.14 in-line.</li>\n<li>Revenue of $426.93M (+8.1% Y/Y) in-line.</li>\n<li>\n<p>The Company is updating its outlook for the fifty-three weeks ending January 3, 2026 (âfiscal 2025â) as follows:</p>\n<div><div class=\"table-responsive\">\n<span class=\"sa-table-scroll-wrapper sa-hide-scrollbar\"><span data-intersection-boundary=\"start\" data-test-id=\"table-scroll-wrapper-boundary-start\"></span><div class=\"table-responsive\">\n<span class=\"sa-table-scroll-wrapper sa-hide-scrollbar\"><span data-intersection-boundary=\"start\" data-test-id=\"table-scroll-wrapper-boundary-start\"></span><table><tbody>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>Current</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>Previous</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Net sales</p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$1.67 billion to $1.68 billion</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$1.67 billion to $1.69 billion</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Comparable store sales growth over fiscal 2024<sup>2</sup></p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>4.0% to 4.5%</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>3.0% to 4.5%</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Net income</p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$17 million to $21 million, or $0.10 to $0.13 per diluted share</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$47 million to $58 million, or $0.29 to $0.36 per diluted share</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Adjusted net income<sup>3</sup></p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$71 million to $75 million, or $0.44 to $0.46 per diluted share</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$67 million to $78 million, or $0.41 to $0.48 per diluted share</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Adjusted EBITDA<sup>3</sup></p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$252 million to $257 million</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$252 million to $267 million</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>Capital expenditures</p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$105 million to $120 million</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>$125 million to $140 million</p></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\"><p>New store openings</p></td>\n<td colspan=\"1\" rowspan=\"1\"><p>25</p></td>\n<td colspan=\"1\" rowspan=\"1\"></td>\n<td colspan=\"1\" rowspan=\"1\"><p>25</p></td>\n</tr>\n</tbody></table>\n<span data-intersection-boundary=\"end\" data-test-id=\"table-scroll-wrapper-boundary-end\"></span></span><button class=\"sa-table-enlarge-button\" type=\"button\">Click to enlarge</button>\n</div>\n<span data-intersection-boundary=\"end\" data-test-id=\"table-scroll-wrapper-boundary-end\"></span></span><button class=\"sa-table-enlarge-button\" type=\"button\">Click to enlarge</button>\n</div></div>\n</li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511955-savers-value-village-non-gaap-eps-of-0_14-in-line-revenue-of-426_93m-in-line",
            "pub_date": "2025-10-31 05:40:44",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        }
    ]
}